Items | Variables | Number exposed | Percent exposed | p-valuec | ||
---|---|---|---|---|---|---|
Case (N = 50) | Control (N = 79) | Case | Control | |||
Demographic characteristics | Sex | 0.19 | ||||
Male | 30 | 38 | 60.0 | 48.1 | ||
Female | 20 | 41 | 40.0 | 51.9 | ||
Age group | 0.11 | |||||
<3y | 7 | 9 | 14 | 11.4 | ||
4–12y | 26 | 32 | 52 | 40.5 | ||
13–49y | 9 | 30 | 18 | 38.0 | ||
>50y | 8 | 8 | 16 | 10.1 | ||
Symptoms before sARI a | Fever | 0.37 | ||||
37.5 °C–37.9 °C | 10 | 27 | 20 | 34.2 | ||
38.0 °C–38.9 °C | 25 | 34 | 50 | 43.0 | ||
39.0 °C − 39.9 °C | 13 | 16 | 26 | 20.2 | ||
40.0 °C–40.9 °C | 2 | 2 | 4 | 2.5 | ||
Cough | 47 | 68 | 94 | 86.1 | 0.16 | |
Bloody sputum | 1 | 0 | 2 | 0.0 | 0.39* | |
Pulmonary Infiltrate | 7 | 5 | 14 | 6.3 | 0.16* | |
Underlying conditions b | Pregnant | 1 | 2 | 2.0 | 2.5 | 0.67* |
Obesity | 3 | 1 | 6.0 | 1.3 | 0.16* | |
Smoker | 7 | 6 | 14.0 | 7.6 | 0.24 | |
Drinks alcohol | 1 | 1 | 2.0 | 1.3 | 0.63* | |
Underlying disease | 24 | 19 | 48.0 | 24 | 0.00 | |
Pulmonary | 16 | 7 | 32.0 | 8.9 | 0.00 | |
Cardiovascular | 4 | 2 | 8.0 | 2.5 | 0.16* | |
Metabolic | 5 | 1 | 10.0 | 1.3 | 0.03* | |
Renal | 4 | 2 | 8.0 | 2.5 | 0.16* | |
Hepatic | 4 | 6 | 8.0 | 7.6 | 0.59* | |
Neoplastic | 4 | 1 | 8.0 | 1.3 | 0.07* | |
Neurologic | 2 | 2 | 4.0 | 2.5 | 0.50* | |
Immunosuppression | 2 | 0 | 4.0 | 0.0 | 0.15* | |
Number of underlying conditions | 0.012 | |||||
1 | 18 | 15 | 36.0 | 19.0 | ||
2 | 3 | 4 | 6.0 | 5.1 | ||
≥3 | 3 | 0 | 6.0 | 0.0 | ||
Vaccination history | Seasonal influenza vaccination in past 5 years | 16 | 17 | 32.0 | 21.5 | 0.18 |
Pandemic H1N1 vaccination | 2 | 2 | 4.0 | 2.5 | 0.50* | |
Exposure to ILI before ILI onset | At home or work | 26 | 42 | 52.0 | 53.2 | 0.90 |
At home | 14 | 13 | 28.0 | 16.5 | 0.12 | |
At work place | 16 | 27 | 32.0 | 34.2 | 0.80 |